Zobrazeno 1 - 10
of 2 544
pro vyhledávání: '"Manns, Mp"'
Publikováno v:
Patient Preference and Adherence, Vol Volume 11, Pp 1647-1656 (2017)
Katharina Schmidt,1 Kathrin Damm,1 Arndt Vogel,2 Heiko Golpon,3,4 Michael P Manns,2 Tobias Welte,3,4 J-Matthias Graf von der Schulenburg1,4 1Leibniz University of Hannover, Center for Health Economics Research (CHERH), Hannover, Germany; 2Department
Externí odkaz:
https://doaj.org/article/d58a26ec96f04212915ad61cbf41588a
Publikováno v:
Cancer Cell International, Vol 4, Iss Suppl 1, p S54 (2004)
Externí odkaz:
https://doaj.org/article/8642df7e821f4b97b98114d0abe7760b
Autor:
Cuenco, J, Wehnert, N, Blyuss, O, Kazarian, A, Whitwell, HJ, Menon, U, Dawnay, A, Manns, MP, Pereira, SP, Timms, JF
The non-invasive differentiation of malignant and benign biliary disease is a clinical challenge. Carbohydrate antigen 19-9 (CA19-9), leucine-rich α2-glycoprotein (LRG1), interleukin 6 (IL6), pyruvate kinase M2 (PKM2), cytokeratin 19 fragment (CYFRA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::d25a7b65f70a2eec46a8413229d9038f
http://hdl.handle.net/10044/1/59789
http://hdl.handle.net/10044/1/59789
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 133:1907-1910
Autor:
Hardtke, S, Abbas, Z, Hamid, S, Ceausu, E, Dalekos, Gn, Niro, G, Corti, Giampaolo, Pinheiro Borzacov LM, Parana, R, Gatselis, Nk, Motoc, A, Ingiliz, P, Muche, M, Wranke, A, Wöbse, M, Yurdaydin, C, Manns, Mp, Wedemeyer, H.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______310::f43b98c42714bc64254b7747ccdc573d
http://hdl.handle.net/2158/1065965
http://hdl.handle.net/2158/1065965
Autor:
Maan, Raoel, van der Meer, Adriaan, Hansen, Bettina, Feld, JJ, Wedemeyer, H, Dufour, JF, Lammert, F, Manns, MP, Zeuzem, S, Janssen, HLA, de Knegt, Rob, Veldt, Bart
Publikováno v:
Journal of Gastroenterology and Hepatology, 30(6), 1057-1064. Wiley-Blackwell Publishing Ltd
Background & AimPegylated interferon-based treatment is still the backbone of current hepatitis C therapy and is associated with bone marrow suppression and an increased risk of infections. The aim of this retrospective cohort study was to assess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::dab89dabdce0048662805961dc8651e0
https://pure.eur.nl/en/publications/5469b56b-418c-494b-8aa9-d9e1e5a3ad84
https://pure.eur.nl/en/publications/5469b56b-418c-494b-8aa9-d9e1e5a3ad84
Autor:
van der MeerAJ, Hansen, Be, Fattovich, Giovanna, Feld, Jj, Wedemeyer, H, Dufour, Jf, Lammert, F, Duarte Rojo, A, Manns, Mp, Ieluzzi, Donatella, Zeuzem, S, Hofmann, Wp, de Knegt RJ, Veldt, Bj, Janssen, H. L. A.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1943::b25d3cb5c71cc3c11485b66c656dc2ec
http://hdl.handle.net/11562/878591
http://hdl.handle.net/11562/878591
Publikováno v:
Zeitschrift für Gastroenterologie. 43:1051-1059
The effects in clinical studies of UDCA on the endpoints "death" or "pre-transplantation survival" can only be shown when UDCA therapy is started in an early disease phase, preferably in stage I but no later than stage II, and is then continued into
Autor:
Brangewitz, M, Schneider, AS, Helfritz, F, Winkler, M, Klempnauer, J, Manns, MP, Wedemeyer, J
Publikováno v:
Endoskopie heute; 20240101, Issue: Preprints
Publikováno v:
Endoskopie heute; 20240101, Issue: Preprints